Key result
Inhibition of the renin-angiotensin system by ACE inhibitors and AT1 receptor antagonists exerts potent anti-atherosclerotic effects by interfering with apoptotic and angiogenic processes.
Answers are grounded in this paper and cite their sources.
ACE inhibitors and AT1 receptor antagonists exert potent anti-atherosclerotic effects by interfering with apoptotic and angiogenic processes, leading to plaque stabilization.
Several recent studies have demonstrated a pivotal role of angiotensin II in the development of atherosclerosis, myocardial infarction, vascular and myocardial remodelling, and congestive heart failure. AT1 receptor-evoked oxidative stress has been implicated in all states of atherosclerosis, starting with the development of endothelial dysfunction and ultimately leading to plaque rupture and myocardial infarction. There is a broad body of evidence showing that growth and apoptosis of vascular smooth muscle and endothelial cells and unrestricted intra-plaque angiogenesis predis[ose to an accelerated onset and progression of atherosclerosis. The potent anti-atherosclerotic effects of inhibition of the renin angiotensin system by ACE inhibitors and AT1 receptor antagonists are, at least in part, based on their interference with apoptotic and angiogenic processes leading ultimately to plaque stabilization and reduced coronary event rates.
No takes yet. Share an insight, caveat, or question.
Nikos Werner (2003) conducted a review in Atherosclerosis. ACE inhibitors and AT1 receptor antagonists was evaluated. Inhibition of the renin-angiotensin system by ACE inhibitors and AT1 receptor antagonists exerts potent anti-atherosclerotic effects by interfering with apoptotic and angiogenic processes.
Synapse has enriched 10 related papers. Consider them for comparative context: